Insmed (INSM) Reports Q4 Loss of $0.85/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Insmed Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
February 23, 2018 7:30 AM ESTOn track to file NDA before the end of March and anticipate a priority reviewExtended amikacin liposome inhalation suspension (ALIS) intellectual property protection to 2035 with issuance of ninth U.S. patentStrengthened cash position through the public offering of $450 million of convertible senior notes in January 2018 Completed the hiring of 71 therapeutic specialists and 5 key account directors to support disease state awareness efforts in the U.S.
BRIDGEWATER, N.J., Feb. 23, 2018 (GLOBE... More
